Core Viewpoint - Zhongke Biological (01237.HK) reported a slight increase in revenue for the first half of 2025, rising by 7.0% to RMB 199.5 million compared to the same period last year [1] Financial Performance - The company recorded a gross profit margin of 12.9%, up from 7.2% in the first half of 2024 [1] - Gross profit for the period was RMB 15.7 million, an increase from RMB 13.4 million in the first half of 2024 [1] - The company achieved a profit of approximately RMB 8.8 million, a turnaround from a loss of RMB 1.7 million in the first half of 2024 [1] Business Segments - The core business segments include the production and sale of wooden products and the production and sale of renewable energy products [1] - Revenue from the two business segments was approximately RMB 198.1 million and RMB 1.4 million, accounting for 99.3% and 0.7% of total revenue, respectively [1]